Journal of the American Heart Association

ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD)

Retrieved on:

화요일, 6월 20, 2023

ZyVersa’s Inflammasome ASC Inhibitor IC 100 inhibits the inflammasome adaptor protein ASC, a component of multiple types of inflammasomes including NLRP3 inflammasomes.

Key Points:

ZyVersa’s Inflammasome ASC Inhibitor IC 100 inhibits the inflammasome adaptor protein ASC, a component of multiple types of inflammasomes including NLRP3 inflammasomes.
In the paper titled, “NLRP3 Inflammasome Activation in Peripheral Arterial Disease,” the authors evaluated human peripheral arteries from patients undergoing limb amputation and serum collected prior to surgery.
Data demonstrated an association between NLRP3, macrophage accumulation, and calcification in arteries of patients with PAD, suggesting that NLRP3 inflammasome activation may be a driver of the disease.
Inhibition of the NLRP3 inflammasome activation or downstream signaling cascade may be beneficial to the reduction of inflammatory-driven PAD.” To read the article, Click Here .

Transforming Heart Disease Prevention for Self-Insured Employers in Oklahoma, Missouri, Kansas, and Arkansas: A Strategic Alliance between Connect Clinic and Cardio Diagnostics

Retrieved on:

수요일, 5월 10, 2023

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced a partnership with Connect Clinic to help MidWest/South Central self-insured employers build access to heart disease initiatives.

Key Points:

Cardio Diagnostics Holdings, Inc (Nasdaq: CDIO), a precision cardiovascular medicine company, today announced a partnership with Connect Clinic to help MidWest/South Central self-insured employers build access to heart disease initiatives.
The innovative collaboration between Connect Clinic and Cardio Diagnostics aims to address this pressing issue by bringing state-of-the-art preventive heart disease testing directly to the workplace.
"The alliance between Connect Clinic and Cardio Diagnostics is a great step forward in the healthcare sector, particularly for self-insured employers in Oklahoma.
By aligning their distinct health services, Connect Clinic and Cardio Diagnostics aim to foster a healthier workforce and create a more sustainable healthcare ecosystem.

The Importance of Mental Wellness for a Healthy Heart and Brain

Retrieved on:

금요일, 5월 5, 2023

In fact, the American Heart Association, the world's leading nonprofit organization focused on heart and brain health, identified a strong interconnection between the mind, heart and body in its scientific statement, " Psychological Health, Well-Being and the Mind-Heart-Body Connection ."

Key Points:

In fact, the American Heart Association, the world's leading nonprofit organization focused on heart and brain health, identified a strong interconnection between the mind, heart and body in its scientific statement, " Psychological Health, Well-Being and the Mind-Heart-Body Connection ."
"The body's biological reaction to stress, anxiety and other types of poor mental health can manifest physically through an irregular heart rate or rhythm, increased blood pressure and inflammation throughout the body.
"Mental health includes our emotional, psychological and social well-being," Levine said.
When we strive to reduce negative aspects of psychological health, we are promoting an overall positive and healthy state of being."

New Family Heart Foundation Study Reveals Systemic Underdiagnosis and Undertreatment of Homozygous Familial Hypercholesterolemia

Retrieved on:

화요일, 5월 2, 2023

A new study from the Family Heart Foundation , a leading research and advocacy organization, showed the diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) is delayed, and often occurs after a heart attack or early atherosclerotic cardiovascular disease (ASCVD).

Key Points:

A new study from the Family Heart Foundation , a leading research and advocacy organization, showed the diagnosis and treatment of homozygous familial hypercholesterolemia (HoFH) is delayed, and often occurs after a heart attack or early atherosclerotic cardiovascular disease (ASCVD).
HoFH is a rare disease and is the most severe form of the common inherited genetic disorder called familial hypercholesterolemia (FH).
“This Family Heart Foundation study demonstrates missed opportunities for HoFH diagnosis across the lifespan, with many adults in the U.S. still undiagnosed, leading to very real consequences from early heart attacks or strokes,” said Mary P. McGowan, M.D., chief medical officer, Family Heart Foundation, and co-author of the study.
The study examined the HoFH population in two proprietary Family Heart Foundation databases: CASCADE FH® Registry and the Family Heart Database™.

5 Sleep Habits Essential for Heart Health

Retrieved on:

금요일, 3월 10, 2023

Unfortunately, we know as many as 1 in 3 people do not get their recommended amount of sleep each night."

Key Points:

Unfortunately, we know as many as 1 in 3 people do not get their recommended amount of sleep each night."
According to Lloyd-Jones, the amount of sleep and quality of sleep are important, and both can have significant impacts on cardiovascular health, as well as overall health.
Research in the " Journal of the American Heart Association " shows maintaining a consistent sleep pattern may play an important role in preventing cardiovascular disease.
"The American Heart Association recently added sleep to the list of factors that support optimal cardiovascular health.

Seniors Get Ultimate Gift at Surprise Holiday Party with over 25,000 Lights, Musicians, and Hundreds of Visitors

Retrieved on:

화요일, 12월 6, 2022

The sentimental three-minute holiday production was created in partnership with the Tony Stacey Centre for Veterans Care and shines a spotlight on the power of community and connection.

Key Points:

The sentimental three-minute holiday production was created in partnership with the Tony Stacey Centre for Veterans Care and shines a spotlight on the power of community and connection.
According to the TSCVC, 75 percent of its residents dont receive any visitors during the holiday season.
For many seniors, the ongoing COVID-19 pandemic has only made loneliness worse, and the holidays can be an especially difficult time.
In 2019, the CW Network featured Klicks Epic Office Holiday Remix with Andrew Huang on its Greatest Holiday Commercials Countdown show.

Mayo Clinic and PN Medical Publish Study that Shows How to Reduce Stress and Anxiety

Retrieved on:

수요일, 8월 31, 2022

Integral to the study was the participants use of BREATHER FIT , one of PN Medical's Combined Respiratory Muscle Training (cRMT) devices.

Key Points:

Integral to the study was the participants use of BREATHER FIT , one of PN Medical's Combined Respiratory Muscle Training (cRMT) devices.
Participation criteria included employment at Mayo Clinic serving front line patients and having access to a smart device they would be willing to utilize for study participation.
Specifically, we looked at the impact of this program on stress and sleep, with doctors and others on the front line of healthcare, said Brent Bauer, M.D., from Mayo Clinic.
The study found that participants generally experienced favorable results and stress was reduced by an average of 18%.

Allelica's Health Economics Study Demonstrates Cost Savings of Polygenic Risk Score in Heart Attack Prevention

Retrieved on:

목요일, 7월 7, 2022

NEW YORK, July 7, 2022 /PRNewswire/ -- Allelica, a leading genomic software company specializing in secure and scalable solutions to implement clinical-grade PRS, has published a health economics study in the Journal of the American Heart Association. The study's authors concluded that integrating PRS as an additional risk-enhancing factor in the Pooled Cohort Equation (PCE) risk assessment (the standard of care for determining the risk of atherosclerotic cardiovascular disease) is cost-saving for US healthcare systems.

Key Points:

"The results of this study showed us that adding PRS to the standard of care not only improves individual health outcomes; it saves money.
Allelica health economist Dr. Deo Mujwara led the study, in collaboration with experts from both industry and academia at Illumina Inc. and the University of Sydney.
The risk of developing CAD, the effectiveness of statin prevention therapy, and the cost of treating CAD had the largest impact on the cost per qualityadjusted lifeyear gained.
Allelica is a leading genomic software company that specializes in secure and scalable solutions to implement clinical-grade polygenic risk scores (PRSs).

Chiesi USA Announces First Analysis from the CAMEO Registry Assessing KENGREAL® (cangrelor) Use and Transition to Oral P2Y12 Inhibitors in Routine Clinical Practice

Retrieved on:

수요일, 6월 1, 2022

CARY, N.C., June 01, 2022 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced its first full analysis publication from the CAMEO (Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes) registry that evaluated KENGREAL (cangrelor) use and transition to oral P2Y12 inhibitors in routine clinical practice.

Key Points:

CARY, N.C., June 01, 2022 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee), the U.S. affiliate of Chiesi Farmaceutici, an international research-focused healthcare Group (Chiesi Group), today announced its first full analysis publication from the CAMEO (Cangrelor in Acute Myocardial Infarction: Effectiveness and Outcomes) registry that evaluated KENGREAL (cangrelor) use and transition to oral P2Y12 inhibitors in routine clinical practice.
The registry aims to collect information on 3,000 patients with NSTEMI or STEMI treated with KENGREAL or an oral P2Y12 inhibitor among 12 sites.
Sites were selected to represent a wide geographic distribution and variety of types of U.S. university- and non-university based hospitals.
The analysis was able to characterize KENGREAL dosing and patterns of transition to an oral P2Y12 inhibitor in routine practice.

Eko Recognized with Second Consecutive MedTech Breakthrough Award for AI Innovation in Healthcare

Retrieved on:

목요일, 5월 5, 2022

MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.

Key Points:

MedTech Breakthrough is an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.
This technology provides frontline healthcare professionals with a reliable, affordable, and scalable solution to screen for cardiovascular disease.
The result is improved diagnosis and this technology from Eko is a true breakthrough in every sense of the word.
The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough health and medical companies and products in categories that include Patient Engagement, mHealth, Health & Fitness, Clinical Administration, Healthcare IoT, Medical Data, Healthcare Cybersecurity and more.